Delivery Order SPE2DB22D1202-SPE2DB24FUFL0
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,435.90, is for the delivery of Addyi 100 mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a $3,326.74 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Addyi (flibanserin) 100 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This contract is classified as a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and was awarded competitively without set-aside designation on December 16, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Addyi 100 mg tablets in quantities of 30 units, valued at $4,767.92. This competitively awarded, non-set-aside contract was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and operates under firm fixed pricing terms. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,856.38 firm fixed-price delivery order is for the supply of ADDYI 100 MG Tablets. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp is for the delivery of Addyi 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,935.74 and a completion date of January 23, 2025. The contracting agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisitions, and technical services to the U.S. military. The contract does not have a set-aside designation, indicating it was awarded through open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserene) 100 mg tablets in quantities of 30 units, with a ceiling value of $41,739.01. This firm fixed price delivery order, awarded September 4, 2025, with ultimate completion by September 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADDYI 100 MG TABLET pharmaceuticals. The $3,199.38 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.19 to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency issued a $16,894.22 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for ADDYI 100 mg tablets (flibanserin) in 30-count units, with ultimate completion March 11, 2026. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at up to $999,999,999 through December 2026, enabling delivery of a broad range of pharmaceutical products and medical supplies to support...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUFL0Delivery Order
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,601,402 units of the prescription medication Addyi (flibanserin) 100 mg tablets. The $17,032.71 firm-fixed-price delivery order has an ultimate completion date of October 26, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 10/25/23 |